Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...
Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...
How the tobacco industry rebranded a brutally addictive drug from deadly to desirable—and what it means for our health.
The tobacco industry rebranded a brutally addictive drug from deadly to desirable—and the longer-term health consequences may ...
Dormant lung cancer cells change their shape from spindle shaped (above) to round (below), which helps protect them from the body's immune defenders.
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...
A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...
3don MSN
Autologous T cell therapy targeting multiple antigens shows promise in treating pancreatic cancer
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
News-Medical.Net on MSN
DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...
In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results